German  |  English
Features for this Basic Statistic
 

For download of graph → register for free
Download als JPG Download JPG
Download JPG Download Powerpoint
Download als Excel-Statistik Download Excel
Print Print
Add To Favorites Add To Favorites
Do you have a question or a suggestion for this statistic? Please visit our contact page.
More statistics about...
 
You may also be interested in...
 
Top Topics
 
Photo: istockphoto.com / alekup

HIV/AIDS worldwide

Photo: sxc.hu / lockstockb

Health

More on Health & Pharmaceuticals

Show all topics
We are celebrating
 
International Year of Statistics 2013Statistics have powerful and far-reaching effects on everyone, yet most people are unaware of their connection and how statistics improve their lives. 2013 is the International Year of Statistics, a worldwide event supported by nearly 1,900 organizations - and we are part of it!learn more
Recommended Websites
 

Do you know of an interesting website related to this topic? Suggest here

Most popular questions
 

Eli Lilly's R&D expenditure as a share of revenue 2007-2012

 

Eli Lilly and Company's spending for research and development as a share of revenue from 2007 to 2012*

Register for free and benefit from the following extras:

  • Access to more than 10,000 statistics
  • Printing and download of PPT, XLS and JPEG files
  • Bookmark favorites in your profile

Worldwide; 2007 to 2012 Source: Eli Lilly and Company


© Statista 2013

Reading support:
This statistic depicts the spending on research and development by Eli Lilly and Company, shown as a share of revenue from 2007 to 2012. In 2007, the company spent some 18.7 percent of its revenue for R&D purposes.

HTML code to embed chart as JPG (FAQ)
Statistic Information
 
close Markets and sectors
Health & Pharmaceuticals , Medicine & Pharmaceuticals
Survey
Survey by  Get Free Basic Account
Survey name  Get Free Basic Account
Survey time period 2007 to 2012
Object of investigation Key figures pharmaceutical company Eli Lilly
Region Worldwide
Macroregion Trans-Continental only (with GER)
Type time series
Category business company, capital asset/cost
Relevance 3
Release
Published by Eli Lilly
Source link  Get Free Basic Account
Release date February 2013
Cataloging
Tags drug, Eli Lilly, expenditure, Lilly, Pharma Industry, Pharma Industry, pharmaceutical companies, Pharmaceutical companies, pharmaceutical companies, pharmaceutical industry, pharmaceutical market, pharmaceuticals, Pharmaceuticals, R & D, R&D, R&D, Research and Development, revenue share, revenue share, spending
Top tags expenditure, R&D, Lilly
Markets and sectors Health & Pharmaceuticals, Medicine & Pharmaceuticals
Further information * Shares of net revenue. All values have been calculated based on the company's selected financial data.
** Quoted from the 2011 annual report.
Popular statistics
 
Viewed by other users
 
Latest statistics
 
Related reports
 
to: expenditure, R&D
Top statistics from the category: Health & Pharmaceuticals

Health & Pharmaceuticals

More on Health & Pharmaceuticals

Medicine & Pharmaceuticals

More on Medicine & Pharmaceuticals

How you can access Statista